SCHEMBL4766463

SCHEMBL4766463

CC(C)(C)OC(=O)N1C(=O)/C(=C/c2cccc(Cl)c2)c2ccc(Br)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 1/20 0.41
TP53 P04637 1/20 0.41
MDM2 Q00987 1/20 0.41
PPARG P37231 2/20 0.39
PLK4 O00444 1/20 0.37
CDK1 P06493 2/20 0.37
APP P05067 1/20 0.37
MAPT P10636 1/20 0.37
SNCA P37840 1/20 0.37
ERBB2 P04626 1/20 0.37
STAT3 P40763 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
BCHE P06276 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NOD1 Q9Y239 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
STS P08842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13929141 1.00 MDM4 (0.41) MDM4TP53MDM2PPARGPLK4
SCHEMBL274463 0.92 MDM4 (0.43) MDM4TP53MDM2PPARGAPP
SCHEMBL277025 0.92 MDM4 (0.43) MDM4TP53MDM2PPARGAPP
SCHEMBL274462 0.92 MDM4 (0.43) MDM4TP53MDM2PPARGAPP
SCHEMBL275408 0.88 PPARG (0.50) MDM4TP53MDM2PPARGAPP
SCHEMBL275409 0.88 PPARG (0.50) MDM4TP53MDM2PPARGAPP
SCHEMBL279251 0.88 PPARG (0.50) MDM4TP53MDM2PPARGAPP
SCHEMBL27740824 0.87 MDM4 (0.51) MDM4TP53MDM2PPARGCDK1
SCHEMBL13929070 0.85 MDM2 (0.39) MDM4TP53MDM2PPARGAPP
SCHEMBL699531 0.85 MAPT (0.43) MDM4TP53MDM2PPARGAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996590-B1 SPIROINDOLINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-10-06 EP disclosed
EP-1996590-A1 SPIROINDOLINONE DERIVATIVES F. Hoffmann-la Roche AG (CH) 2008-12-03 EP disclosed
WO-2007104664-A1 SPIROINDOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-09-20 WO disclosed
WO-2007104664-A1 SPIROINDOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-09-20 WO disclosed
US-20070213341-A1 Spiroindolinone derivatives CHEN LI 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213341-A1 Spiroindolinone derivatives MKI67, PKD1, RCC2 MDM4 1779/4885TP53 25/4885MDM2 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.